Page 3 - Inhalation Powder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management

Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers . | June 6, 2023

Proair digihalerManny montalvoArmonair digihalerDeepak thomasAirduo digihalerTeva digihalerDigital health innovationTeva pharmaceuticalsTeva pharmaceuticalTeva pharmaceutical industries ltdPhil incUpper airway symptomsPhilrx patient accessPhilrx patient access platformDigital healthChief executive officer

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings

Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in. | April 18, 2023

United statesHotel washingtonDistrict of columbiaFairfax hospitalAndrew nelsenJames gagermeierColleen mcevoySean francoisJorge malleaNader moazamiKarim el kershRobert montgomeryInformationfor remodulinSandeep sahaySteven nathanRaymond benza

Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American Colle

Findings from the first clinical trial program comparing the use of Teva’s Digihaler® System to standard of care in asthma management will be presented across six abstractsTEL AVIV, Israel & PARSIPPANY, N.J. (BUSINESS WIRE) Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NY.

United statesProair digihalerYael ashmanTeva digihalerRandall brownAirduo digihalersAirduo digihalerAffairs at tevaAmerican college of allergyDrug administrationTeva pharmaceutical industries ltdDigital health platformInternational congressDigital healthEuropean respiratory societyTeva pharmaceuticals united states inc

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesVanderbilt universityJanet bickelSandeep sahayElisa lancasterJames klingerDewey steadmanJean elwingAndrew nelsenR james whiteUnited therapeutics corporationExchange commissionUnited therapeutics corporation nasdaqAmerican college of chest physiciansOmni nashville hotelUniversity of cincinnati

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesInova fairfax hospitalSteven nathanPeter smithDewey steadmanExchange commissionUnited therapeutics corporation nasdaqUnited therapeutics corporationDrug administrationGlobal product developmentInhalation solutionTherapeutics corporationMedical directorAdvanced lung diseaseLung transplant programFalls church